comprehensive -WSS

comprehensive

author：comprehensive 2025-10-03 01:02:27 - browse：6487

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Melinda French Gates resigns from Gates Foundation

hotspot

leisure time

WSS

Diverse clinical trials: Why aren’t we there yet?

Cue Health's Covid

Generate Biomedicines machine learning biotech raises $273M

Orangutan used medicinal plant to treat wound, first time ever seen

Walmart eyes Medicare Advantage provider ChenMed

How to make the FDA’s new prescription one

explore

comprehensive

Wikipedia

Alkermes shareholders re

IRA could hurt research into orphan drugs for rare diseases

Peter Hotez and the public health issue of online harassment

Private equity could exacerbate cardiology's overuse problem, experts fear

How one medical school became remarkably diverse

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Anesthesiologist group: stop taking Ozempic before surgery

Guidelines to prevent youth baseball injuries need more muscle

Private equity could exacerbate cardiology's overuse problem, experts fear

entertainment

Why does health care cost so much? A reading guide

Getting Alzheimer's drug Leqembi to patients can be a challenge

Food makers to regulators: Ultra

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

FDA proposes changes to key medical devices approval pathway

FDA panel endorses Alnylam’s heart drug — after picking it apart

hotspot

hotspot

leisure time

explore